Trials / Recruiting
RecruitingNCT05219422
Testing ALERT With GTO in Middle Schools
Improving the Implementation of Evidence-based Drug Prevention Programs in Schools
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 42 (estimated)
- Sponsor
- RAND · Academic / Other
- Sex
- All
- Age
- 11 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
To test the efficacy of Project ALERT with the support enhancement tool, Getting To Outcomes.
Detailed description
This study combines two programs that have been developed by RAND researchers: Project ALERT (PA) and Getting to Outcomes (GTO). Project ALERT is a widely used drug prevention program for middle school youth. Though it has an evidence-base for effectiveness, the program (like most evidence-based programs in schools) is not run with adequate fidelity representing a large gap between what is developed and tested for effectiveness and what is used in actual practice. Thus, the study will conduct an updated randomized controlled trial of PA and test GTO as a tool to increase adoption and adequate fidelity of the program in schools. GTO's previous evidence suggests it could be effective in public schools, yet this remains an empirical question. A successful demonstration of PA and GTO could fundamentally transform evidence-based prevention's delivery, reach, and thus impact, in the US.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Project ALERT | 14 session drug prevention program for 7th and 8th grade youth. |
| BEHAVIORAL | Getting to Outcomes | The Getting To Outcomes (GTO) implementation support intervention provides technical assistance, training, guides, and tools to improve community-based practitioners capacity to complete tasks associated with implementing an EBP, which in turn leads to improved implementation fidelity. |
Timeline
- Start date
- 2022-08-30
- Primary completion
- 2026-03-31
- Completion
- 2026-03-31
- First posted
- 2022-02-02
- Last updated
- 2026-02-20
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05219422. Inclusion in this directory is not an endorsement.